Revolutionising hydrogen water with Aquela 8.0
We have been the market leader in the development of H2 water technology since 2000. We have also been involved in research into the potential therapeutic benefits of H2 water.
It is easy to produce hydrogen water – either by electrolysing water or by dissolving alkaline earth metal compounds. However, these processes turn the pH of water to alkaline and may produce chemical by-products.
In 2007, Ecomo International launched Aquela Blue, which was the world’s first neutral pH, saturated hydrogen water server. This significant breakthrough was the culmination of our early efforts to achieve the safety and quality sought by researchers and clinical physicians in their endeavour to evaluate the potential benefits of hydrogen water.
A dose-dependent response is observed in the effect of any medicine. We were among the first to recognize its importance in the clinical application of hydrogen water. This led to the development of Aquela 7.0, which could generate pure hydrogen gas and produce 7 ppm super saturated hydrogen water without affecting the pH and taste of water. We sold 26 million units of Aquela 7.0 in Japan between 2012 and 2017. Meanwhile, we participated in clinical studies on the potential benefits of molecular hydrogen and some of the results have been published in peer-reviewed international medical journals (1,2, 3).
Aquela Global was founded in 2018 with an aim to manufacture Aquela 8.0 in the United Kingdom and distribute it throughout Europe, the Middle East, Africa and South Asia. Aquela 8.0 generates pure hydrogen gas and produces record-breaking 8 ppm super saturated hydrogen water (PCT application in January 2018). This is of course without affecting the pH and taste of water.
Brand new Aquela 8.0 is manufactured at the state-of-the-art GMP facility. GMP stands for Good Manufacturing Practice and are the practices required to conform to the guidelines for the manufacturing and sales of pharmaceutical and supplement products.